What is the recommended starting dose, titration, monitoring, and contraindications for lisinopril in an adult with hypertension?

Lisinopril for Hypertension in Adults

Starting Dose

For adults with hypertension, initiate lisinopril at 10 mg once daily, or 5 mg once daily if the patient is already taking a diuretic. 1

• The FDA-approved starting dose is 10 mg once daily for most adults with hypertension 1
• If the patient is volume-depleted or on concurrent diuretic therapy, start at 5 mg once daily to minimize first-dose hypotension 1
• In patients with low systolic blood pressure (≤120 mmHg but >100 mmHg), consider starting at 2.5 mg daily 1

Titration Strategy

Titrate lisinopril according to blood pressure response, with a usual maintenance range of 20–40 mg once daily; doses up to 80 mg have been studied but provide minimal additional benefit. 1

• The typical effective dose range is 20–40 mg once daily 1
• Doses above 40 mg (up to 80 mg) have been used but do not appear to give significantly greater antihypertensive effect 1
• Ensure each dose is titrated to an effective level before adding another antihypertensive agent 2
• Re-measure blood pressure 2–4 weeks after any medication change 2
• Target blood pressure should be achieved within 3 months of initiating or intensifying therapy 2

Dose-Response Evidence

• Clinical trials demonstrate a linear dose-response relationship across the 1.25–80 mg daily range 3
• Lisinopril 10 mg and 20 mg produce similar peak antihypertensive effects, both greater than 2.5 mg but less than 80 mg 4
• The antihypertensive response at 24 hours post-dose appears dose-related across the 2.5–80 mg range 4

Blood Pressure Targets

Target systolic blood pressure of 120–129 mmHg is recommended for well-tolerated therapy, with a minimum goal of <140/90 mmHg. 2

• Intensive blood pressure lowering to 120–129 mmHg systolic markedly reduces cardiovascular morbidity and mortality in patients ≥70 years 2
• At minimum, achieve <140/90 mmHg in all hypertensive adults 2

Combination Therapy

If blood pressure remains uncontrolled on lisinopril alone, add a low-dose thiazide-like diuretic (e.g., hydrochlorothiazide 12.5 mg) rather than increasing lisinopril beyond 40 mg. 1

• The International Society of Hypertension recommends ACE inhibitors or ARBs as first-line agents for non-Black adults 2
• When blood pressure remains ≥140/90 mmHg, the preferred three-drug regimen is an ACE inhibitor + dihydropyridine calcium-channel blocker + thiazide-like diuretic 2
• Never combine two renin-angiotensin system blockers (e.g., ACE inhibitor + ARB), as this increases adverse events without added benefit 2
• Fixed-dose single-pill combinations improve adherence 2

Comparative Effectiveness

• Lisinopril demonstrated superior reductions in systolic and diastolic blood pressure compared to hydrochlorothiazide in a predominantly Caucasian population 1
• Lisinopril was approximately equivalent to atenolol and metoprolol for diastolic blood pressure reduction, with somewhat greater effects on systolic blood pressure 1
• However, thiazide diuretics (chlorthalidone) have been shown superior to lisinopril in preventing heart failure events in elderly hypertensive patients 2

Monitoring Requirements

Monitor serum potassium and creatinine 2–4 weeks after initiating lisinopril or any dose adjustment, and assess for orthostatic hypotension at each visit. 2

• Check serum potassium and creatinine when initiating an ACE inhibitor or thiazide-like diuretic 2
• Re-measure blood pressure 2–4 weeks after any medication change 2
• Assess for orthostatic hypotension at every visit, particularly in older adults 2
• Verify medication adherence at every encounter 2

Common Monitoring Pitfalls

• Hyperkalemia risk: Monitor potassium closely, especially when combined with potassium supplements or potassium-sparing diuretics 5, 6
• Acute kidney injury: Watch for azotemia, particularly in patients with renovascular disease or volume depletion 5
• Cough: Class-related adverse effect occurring in a subset of patients; if intolerable, consider switching to an ARB 2, 5

Contraindications and Precautions

Lisinopril is contraindicated in pregnancy, bilateral renal artery stenosis, history of angioedema with ACE inhibitors, and concurrent use with another renin-angiotensin system blocker. 2, 5

Absolute Contraindications

• Pregnancy (all trimesters) 5
• History of angioedema with ACE inhibitors 5
• Concurrent use with another ACE inhibitor or ARB 2

Relative Contraindications and Cautions

• Bilateral renal artery stenosis or stenosis in a solitary kidney (risk of acute renal failure) 1
• Severe aortic stenosis 5
• Hyponatremia (serum sodium <130 mEq/L): start at lower dose 1
• Volume depletion: correct before initiating or start at reduced dose 1

Race-Based Considerations

• Lisinopril is less effective in reducing blood pressure in Black patients compared to Caucasians 1
• For Black patients with hypertension, consider initiating with a calcium-channel blocker or thiazide diuretic instead 2

Renal Dose Adjustments

No dose adjustment is required for creatinine clearance >30 mL/min; reduce initial dose by 50% for CrCl 10–30 mL/min, and start at 2.5 mg for hemodialysis or CrCl <10 mL/min. 1

• CrCl >30 mL/min: No adjustment needed 1
• CrCl 10–30 mL/min: Start at 5 mg for hypertension (half the usual dose); titrate as tolerated to maximum 40 mg daily 1
• CrCl <10 mL/min or hemodialysis: Start at 2.5 mg once daily 1
• Lisinopril accumulates in renal dysfunction due to primarily renal excretion 5, 6

Dosing Frequency Considerations

Once-daily dosing is standard and FDA-approved; twice-daily dosing does not provide consistent additional benefit and may increase adverse events. 1, 7

• The FDA label recommends once-daily administration 1
• One small retrospective study suggested twice-daily dosing (20 mg BID vs 40 mg once daily) achieved greater systolic blood pressure reduction (10.2 mmHg difference) 8
• However, a larger real-world study of 11,210 patients found no difference in blood pressure control between once-daily and twice-daily dosing, with twice-daily lisinopril 10 mg associated with increased odds of angioedema (OR 2.27,95% CI 1.13–4.58) 7
• Stick with once-daily dosing as recommended by the FDA label 1

Key Adverse Effects

• Cough: Most frequently reported class-related adverse effect 5, 6
• Angioedema: Rare but serious; more common in Black patients 5
• Hypotension: Particularly with first dose in volume-depleted patients 1, 5
• Hyperkalemia: Monitor potassium, especially with concurrent potassium supplements or renal impairment 5, 6
• Azotemia: Reversible elevation in creatinine, particularly in renovascular disease 5
• Dizziness, rash, and proteinuria have been reported in small numbers of patients 6